Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Open accessAbstract
The promise of gene therapy for the treatment of cystic fibrosis has yet to be fully clinically realized despite years of effort toward correcting the underlying genetic defect in the cystic fibrosis transmembrane conductance regulator (CFTR). mRNA therapy via nanoparticle delivery represents a powerful technology for the transfer of genetic material to cells with large, widespread populations, such as airway epithelia. We deployed a clinically relevant lipid-based nanoparticle (LNP) for packaging and delivery of large chemically modified CFTR mRNA (cmCFTR) to patient-derived bronchial epithelial cells, resulting in an increase in membrane-localized CFTR and rescue of its primary function as a chloride channel. Furthermore, nasal application of LNP-cmCFTR restored CFTR-mediated chloride secretion to conductive airway epithelia in CFTR knockout mice for at least 14 days. On day 3 post-transfection, CFTR activity peaked, recovering up to 55% of the net chloride efflux characteristic of healthy mice. This magnitude of response is superior to liposomal CFTR DNA delivery and is comparable with outcomes observed in the currently approved drug ivacaftor. LNP-cmRNA-based systems represent a powerful platform technology for correction of cystic fibrosis and other monogenic disorders.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418 · see citing works
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523 · see citing works
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,667 · see citing works
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M. C., Rozmahel, R. F., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,238 · see citing works
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728 · see citing works
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works
Naehrlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,535 · see citing works
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1× · see citing works
“Previous and ongoing work has successfully yielded particles specifically engineered for endosomal escape, resulting in increased cmRNA payload and boosted protein expression.(42,110) Exploitation of additional particle dissociation mechanisms and endosome-perturbing pathways can be employed to enhance this effect.”
BackgroundGilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681 · see citing works
Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid
Zabner, J., Fasbender, A., Moninger, T., Poellinger, K. A., & Welsh, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18997 · Cited by 1,408 · see citing works
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Goor, F. V., Hadidaꝉ, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A. K., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,225 · see citing works
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208 · see citing works
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139 · see citing works
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088 · see citing works
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · see citing works
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050 · see citing works
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014 · see citing works
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948 · see citing works
Self-citationSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasiç, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 878 · see citing works
Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. J. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 824 · see citing works
Sabnis, S., Kumarasinghe, E. S., Salerno, T., Mihai, C., Ketova, T., Senn, J. J., Lynn, A., Bulychev, A., McFadyen, I., Chan, J., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.010 · Cited by 820 · see citing works
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M., Dunitz, J., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 803 · see citing works
Tools for translation: non-viral materials for therapeutic mRNA delivery
Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799 · see citing works
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719 · see citing works
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C. C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 710 · see citing works
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Wittrup, A., Ai, A., Liu, X., Hamar, P., Trifonova, R., Charisse, K., Manoharan, M., Kirchhausen, T., & Lieberman, J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3298 · Cited by 693 · see citing works
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685 · see citing works
Origins of Cystic Fibrosis Lung Disease
Stoltz, D. A., Meyerholz, D. K., & Welsh, M. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300109 · Cited by 669 · see citing works
Kulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663 · see citing works
Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642 · see citing works
Mechanism of oligonucleotide release from cationic liposomes.
Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634 · see citing works
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624 · see citing works
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R. A., & Hanes, J. S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597 · see citing works
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer
Drumm, M. L., Pope, H. A., Cliff, W. H., Rommens, J. M., Marvin, S. A., Tsui, L., Collins, F. S., Frizzell, R. A., & Wilson, J. M. (1990) · Cell · doi:10.1016/0092-8674(90)90398-x · Cited by 576 · see citing works
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Rowe, S. M., Daines, C., Ringshausen, F. C., Kerem, E., Wilson, J., Tullis, E., Nair, N., Simard, C., Han, L., Ingenito, E. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709847 · Cited by 522 · see citing works
Chu, C.-S., Trapnell, B. C., Curristin, S. M., Cutting, G. R., & Crystal, R. G. (1993) · Nature Genetics · doi:10.1038/ng0293-151 · Cited by 516 · see citing works
Goor, F. V., Straley, K. S., Cao, D., González, J. E., Hadidaꝉ, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M. A., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 515 · see citing works
Airway Surface Dehydration in Cystic Fibrosis: Pathogenesis and Therapy
Boucher, R. C. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.071905.105316 · Cited by 509 · see citing works
Nanoparticle diffusion in respiratory mucus from humans without lung disease
Schuster, B. S., Suk, J. S., Woodworth, G. F., & Hanes, J. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.064 · Cited by 468 · see citing works
Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
Armstrong, D., Grimwood, K., Carlin, J. B., Carzino, R., Gutiérrez, J. P., Hull, J., Olinsky, A., Phelan, E., ROBERTSON, C. F., & Phelan, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467 · see citing works
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454 · see citing works
Alton, E. W. F. W., Armstrong, D. K., Ashby, D., Bayfield, K. J., Bilton, D., Bloomfield, E. V., Boyd, A. C., Brand, J., Buchan, R., Calcedo, R., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00245-3 · Cited by 428 · see citing works
Chen, D. L., Love, K. T., Chen, Y., Eltoukhy, A. A., Kastrup, C. J., Sahay, G., Jeon, A., Dong, Y., Whitehead, K. A., & Anderson, D. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301621z · Cited by 422 · see citing works
Self-citationStabilization of RNA stacking by pseudouridine
Davis, D. R. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5020 · Cited by 399 · see citing works
Grubb, B. R., Pickles, R. J., Ye, H., Yankaskas, J. R., Vick, R. N., Engelhardt, J. F., Wilson, J. M., Johnson, L. G., & Boucher, R. C. (1994) · Nature · doi:10.1038/371802a0 · Cited by 365 · see citing works
Leung, A. K. K., Hafez, I. M., Baoukina, S., Belliveau, N. M., Zhigaltsev, I. V., Afshinmanesh, E., Tieleman, D. P., Hansen, C. L., Hope, M. J., & Cullis, P. R. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp303267y · Cited by 364 · see citing works
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
Leung, A. K. K., Tam, Y. Y. C., Chen, S., Hafez, I. M., & Cullis, P. R. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b02891 · Cited by 359 · see citing works
Suk, J. S., Lai, S. K., Wang, Y.-Y., Ensign, L. M., Zeitlin, P. L., Boyle, M., & Hanes, J. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.076 · Cited by 355 · see citing works
Yang, Y., Janich, S., Cohn, J. A., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9480 · Cited by 338 · see citing works
Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
Kaczmarek, J. C., Patel, A. K., Kauffman, K. J., Fenton, O. S., Webber, M. J., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201608450 · Cited by 337 · see citing works
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Cholon, D. M., Quinney, N. L., Fulcher, M. L., Esther, C. R., Das, J., Dokholyan, N. V., Randell, S. H., Boucher, R. C., & Gentzsch, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008680 · Cited by 320 · see citing works
Knowles, M. R., Paradiso, A. M., & Boucher, R. C. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.4-445 · Cited by 310 · see citing works
Oh, P., Borgström, P., Witkiewicz, H., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1292 · Cited by 301 · see citing works
Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Ensign, L. M., Schneider, C. S., Suk, J. S., Cone, R. A., & Hanes, J. S. (2012) · Advanced Materials · doi:10.1002/adma.201201800 · Cited by 293 · see citing works
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression
Veit, G., Avramescu, R. G., Perdomo, D., Phuan, P.-W., Bagdany, M., Apaja, P. M., Borot, F., Szollosi, D., Wu, Y.-S., Finkbeiner, W. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008889 · Cited by 287 · see citing works
Paunovska, K., Sago, C. D., Monaco, C. M., Hudson, W. H., Castro, M. G., Rudoltz, T. G., Kalathoor, S., Vanover, D. A., Santangelo, P. J., Ahmed, R., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00432 · Cited by 277 · see citing works
Moss, R. B., Milla, C. E., Colombo, J. L., Accurso, F. J., Zeitlin, P. L., Clancy, J. P., Spencer, L. T., Pilewski, J. M., Waltz, D. A., Dorkin, H. L., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.022 · Cited by 276 · see citing works
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
Lutz, J., Lazzaro, S., Habbeddine, M., Schmidt, K. E., Baumhof, P., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., Heidenreich, R., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0032-6 · Cited by 257 · see citing works
Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA
Patel, S., Ashwanikumar, N., Robinson, E., DuRoss, A., Sun, C., Murphy-Benenato, K. E., Mihai, C., Almarsson, Ö., & Sahay, G. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02664 · Cited by 251 · see citing works
Self-citationCorrection of Lethal Intestinal Defect in a Mouse Model of Cystic Fibrosis by Human CFTR
Zhou, L., Dey, C. R., Wert, S. E., et al. (1994) · Science · doi:10.1126/science.7527588 · Cited by 246 · see citing works
Harvey, B., Leopold, P. L., Hackett, N. R., Grasso, T. M., Williams, P. M., Tucker, A. L., Kaner, R. J., Ferris, B., Gonda, I., Sweeney, T. D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7935 · Cited by 244 · see citing works
Aitken, M. L., Moss, R. B., Waltz, D. A., Dovey, M. E., Tonelli, M. R., McNamara, S., Gibson, R. L., Ramsey, B. W., Carter, B. J., & Reynolds, T. C. (2001) · Human Gene Therapy · doi:10.1089/104303401753153956 · Cited by 238 · see citing works
Abnormal regulation of ion channels in cystic fibrosis epithelia
Welsh, M. J. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.1695593 · Cited by 232 · see citing works
Chance or necessity? Insertional Mutagenesis in Gene Therapy and Its Consequences
Baum, C., Kalle, C. V., Staal, F. J. T., Li, Z., Fehse, B., Schmidt, M., Weerkamp, F., Karlsson, S., Wagemaker, G., & Williams, D. A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.10.013 · Cited by 225 · see citing works
Cystic fibrosis transmembrane conductance regulator: A chloride channel with novel regulation
Welsh, M. J., Anderson, M. P., Rich, D. P., et al. (1992) · Neuron · doi:10.1016/0896-6273(92)90196-k · Cited by 215 · see citing works
Verkman, A. S., Sellers, M. C., Chao, A. C., et al. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90652-0 · Cited by 215 · see citing works
In Vitro Transcription of Long RNA Containing Modified Nucleosides
Pardi, N., Muramatsu, H., Weissman, D., & Karikó, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_2 · Cited by 204 · see citing works
Genistein potentiates wild-type and delta F508-CFTR channel activity
Hwang, T.-C., Wang, F., Yang, I. C., et al. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.3.c988 · Cited by 204 · see citing works
Lipid-Based Nanocarriers for RNA Delivery
Xue, H. Y., Guo, P., Wen, W., & Wong, H. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150531164540 · Cited by 202 · see citing works
Viger-Gravel, J., Schantz, A., Pinon, A. C., Rossini, A. J., Schantz, S., & Emsley, L. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b10795 · Cited by 202 · see citing works
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
Siegwart, D. J., Whitehead, K. A., Nuhn, L., Sahay, G., Cheng, H., Jiang, S., Ma, M., Lytton‐Jean, A. K. R., Vegas, A. J., Fenton, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106379108 · Cited by 193 · see citing works
Self-citationIntracellular Trafficking of Plasmids during Transfection Is Mediated by Microtubules
Vaughan, E. E., & Dean, D. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.10.004 · Cited by 183 · see citing works
Ramalho, A. S., Beck, S., Meyer, M. E., Penque, D., Cutting, G. R., & Amaral, M. D. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2001-0004oc · Cited by 182 · see citing works
Knowles, M. R., Carson, J. L., Collier, A. M., et al. (1981) · PubMed · doi:10.1164/arrd.1981.124.4.484 · Cited by 155 · see citing works
Challenges in carrier‐mediated intracellular delivery: moving beyond endosomal barriers
Stewart, M. P., Lorenz, A. S., Dahlman, J. E., & Sahay, G. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1377 · Cited by 154 · see citing works
Self-citationAssessment of the CFTR and ENaC association
Berdiev, B. K., Qadri, Y. J., & Benos, D. J. (2008) · Molecular BioSystems · doi:10.1039/b810471a · Cited by 142 · see citing works
McNeer, N. A., Anandalingam, K. K., Fields, R. J., Caputo, C. R., Kopic, S., Gupta, A., Quijano, E., Polikoff, L. A., Kong, Y., Bahal, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7952 · Cited by 139 · see citing works
Puchelle, É., Gaillard, D. A., Ploton, D., et al. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.5.485 · Cited by 133 · see citing works
Briel, M., Greger, R. F., & Kunzelmann, K. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.825bp.x · Cited by 122 · see citing works
Lechanteur, A., Sanna, V., Duchemin, A., Évrard, B., Mottet, D., & Piel, G. (2018) · Nanomaterials · doi:10.3390/nano8050270 · Cited by 119 · see citing works
Correia, M. G. S., Briuglia, M. L., Niosi, F., & Lamprou, D. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.025 · Cited by 116 · see citing works
Lentiviral Vectors for Gene Therapy of Cystic Fibrosis
Goldman, M. J., Lee, P., Yang, J.-S., & Wilson, J. M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.18-2261 · Cited by 112 · see citing works
From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking
Farinha, C. M., & Canato, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2387-7 · Cited by 108 · see citing works
Nasal Potential Difference Measurements to Assess CFTR Ion Channel Activity
Rowe, S. M., Clancy, J. P., & Wilschanski, M. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-117-8_6 · Cited by 107 · see citing works
Dosanjh, A., Lencer, W. I., Brown, D. J., et al. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.2.c360 · Cited by 100 · see citing works
Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles
Crawford, R., Dogdas, B., Keough, E., Haas, R. M., Wepukhulu, W., Krotzer, S., Burke, P. A., Sepp‐Lorenzino, L., Bagchi, A., & Howell, B. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.025 · Cited by 96 · see citing works
Lentiviral-mediated phenotypic correction of cystic fibrosis pigs
Cooney, A. L., Alaiwa, M. H. A., Shah, V. S., Bouzek, D. C., Stroik, M. R., Powers, L. S., Gansemer, N. D., Meyerholz, D. K., Welsh, M. J., Stoltz, D. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88730 · Cited by 96 · see citing works
Hubert, D., Chiron, R., Camara, B., Grenet, D., Prévötat, A., Bassinet, L., Dominique, S., Rault, G., Macey, J., Honoré, I., et al. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.03.003 · Cited by 92 · see citing works
Boylan, N. J., Suk, J. S., Lai, S. K., Jelinek, R., Boyle, M., Cooper, M. J., & Hanes, J. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.031 · Cited by 89 · see citing works
A Microplate Assay Measuring Chloride Ion Channel Activity
West, M., & Molloy, C. R. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0377 · Cited by 85 · see citing works
Cholon, D. M., O’Neal, W. K., Randell, S. H., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00016.2009 · Cited by 81 · see citing works
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
Haque, A. K. M. A., Dewerth, A., Antony, J. S., Riethmüller, J., Schweizer, G. R., Weinmann, P., Latifi, N., Yasar, H., Pedemonte, N., Sondo, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34960-0 · Cited by 80 · see citing works
Ren, C. L., Morgan, R. L., Oermann, C., Resnick, H. E., Brady, C., Campbell, A., DeNagel, R., Guill, M., Hoag, J., Lipton, A., et al. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201707-539ot · Cited by 74 · see citing works
Illek, B., Maurisse, R., Wahler, L., Kunzelmann, K., Fischer, H., & Gruenert, D. C. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149783 · Cited by 73 · see citing works
Polyethylenimine-mediated gene delivery to the lung and therapeutic applications
Conese, M. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s2708 · Cited by 71 · see citing works
Jennings, M. T., Dezube, R., Paranjape, S., West, N. E., Hong, G., Braun, A., Grant, J., Merlo, C. A., & Lechtzin, N. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-058oc · Cited by 71 · see citing works
Gindy, M. E., DiFelice, K., Kumar, V., Prud’homme, R. K., Celano, R., Haas, R. M., Smith, J. S., & Boardman, D. (2014) · Langmuir · doi:10.1021/la500630h · Cited by 69 · see citing works
Guggino, W. B., & Cebotaru, L. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1347630 · Cited by 64 · see citing works
Alton, E. W. F. W., Boyd, A., Porteous, D. J., Davies, G., Davies, J. C., Uta Griesenbach, D., Higgins, T., Gill, D. R., Hyde, S. C., & Innes, J. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1193le · Cited by 56 · see citing works
A Simple Method of Mouse Lung Intubation
Das, S., MacDonald, K. D., Chang, H.-Y. S., et al. (2013) · Journal of Visualized Experiments · doi:10.3791/50318 · Cited by 48 · see citing works
Self-citationLoss of Cftr function exacerbates the phenotype of Na+ hyperabsorption in murine airways
Livraghi-Butrico, A., Kelly, E. J., Wilkinson, K. J., Rogers, T. D., Gilmore, R. C., Harkema, J. R., Randell, S. H., Boucher, R. C., O’Neal, W. K., & Grubb, B. R. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00150.2012 · Cited by 44 · see citing works
MacDonald, K. D., McKenzie, K. R., Henderson, M. J., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90221.2008 · Cited by 44 · see citing works
Self-citationAlton, E. W. F. W., Armstrong, D. K., Ashby, D., Bayfield, K. J., Bilton, D., Bloomfield, E. V., Boyd, A., Brand, J., Buchan, R., Calcedo, R., et al. (2016) · Efficacy and Mechanism Evaluation · doi:10.3310/eme03050 · Cited by 44 · see citing works
Ernst, W. L., Shome, K., Wu, C. C., Gong, X., Frizzell, R. A., & Aridor, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692749 · Cited by 37 · see citing works
Carbone, A., Castellani, S., Favia, M., Diana, A., Paracchini, V., Gioia, S. D., Seia, M., Casavola, V., Colombo, C. M., & Conese, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12303 · Cited by 34 · see citing works
Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis
Villate-Beitia, I., Sesma, J. Z., Puras, G., & Pedraz, J. L. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1298122 · Cited by 33 · see citing works
CFTR Folding Consortium: Methods Available for Studies of CFTR Folding and Correction
Peters, K. W., Okiyoneda, T., Balch, W. E., et al. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-120-8_20 · Cited by 32 · see citing works
Pathogenesis of cystic fibrosis airways disease.
Boucher, R. (2001) · PubMed · Cited by 24 · see citing works
Translational research to enable personalized treatment of cystic fibrosis
Hagemeijer, M. C., Siegwart, D. J., Strug, L. J., Cebotaru, L., Torres, M. J., Sofoluwe, A., & Beekman, J. M. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.10.017 · Cited by 22 · see citing works
Jiang, C., Akita, G. Y., Colledge, W. H., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-671 · Cited by 20 · see citing works
Protein and lipid interactions – Modulating CFTR trafficking and rescue
Farinha, C. M., Miller, E. A., & McCarty, N. A. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.08.014 · Cited by 10 · see citing works
Modified h CFTR mRNA restores normal lung function in a mouse model of cystic fibrosisPreprint
Haque, A. A., Dewerth, A., Antony, J. S., Riethmüller, J., Latifi, N., Yasar, H., Weinmann, P., Pedemonte, N., Sondo, E., Laval, J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/202853 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933 · see citing works
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127 · see citing works
Nanomaterial Delivery Systems for mRNA Vaccines
Buschmann, M. D., Carrasco, M. J., Alishetty, S., Paige, M., Alameh, M. G., & Weissman, D. (2021) · Vaccines · doi:10.3390/vaccines9010065 · Cited by 582 · see citing works
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works
Self-citationA Comprehensive Review of mRNA Vaccines
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457 · see citing works
The challenge and prospect of mRNA therapeutics landscape
Weng, Y., Li, C., Yang, T., Hu, B., Zhang, M., Guo, S., Xiao, H., Liang, X.-J., & Huang, Y. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107534 · Cited by 417 · see citing works
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260 · see citing works
Self-citationEffective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide
Qiu, Y., Man, R. C. H., Liao, Q., Kung, K. L. K., Chow, M. Y. T., & Lam, J. K. W. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.026 · Cited by 178 · see citing works
Loughrey, D., & Dahlman, J. E. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00601 · Cited by 173 · see citing works
Nanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139 · see citing works
DeRosa, F., Smith, L., Shen, Y., Huang, Y., Pan, J., Xie, H., Yahalom, B., & Heartlein, M. W. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.001 · Cited by 111 · see citing works
Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
Vlatkovic, I. (2021) · Biomedicines · doi:10.3390/biomedicines9050530 · Cited by 112 · see citing works
Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104 · see citing works
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86 · see citing works
RNA delivery biomaterials for the treatment of genetic and rare diseases
Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works
Zhang, C., Zhang, X., Zhao, W., Zeng, C., Li, W., Li, B., Luo, X., Li, J., Jiang, J., Deng, B., et al. (2019) · Nano Research · doi:10.1007/s12274-019-2308-9 · Cited by 61 · see citing works
Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery
Kim, J., Jozic, A., & Sahay, G. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00619-y · Cited by 61 · see citing works
Self-citation
- Authors
- Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G.
- Affiliations
- Oregon State University (US)
- Corresponding author
- Sahay, Gaurav
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 26
- Issue
- 8
- Pages
- 2034-2046
- ISSN
- 1525-0016 (ISSN-L)
- PMC
- PMC6094356
- OpenAlex
- W2808558611
- Cited by
- 272
- References
- 118
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 40 · 2023: 44 · 2022: 55 · 2021: 30 · 2020: 28 · 2019: 18 · 2018: 3
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cystic Fibrosis Foundation
- OSU College of Pharmacy
- National Institute of Biomedical Imaging and Bioengineering (1R15EB021581-01)
- National Institute of General Medical Sciences (1R35GM119839-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- cystic fibrosis, CFTR, lipid nanoparticles, chemically modified mRNA, mRNA therapeutics, chloride secretion, airway epithelial cells, intranasal drug delivery, CFTR knockout mice, gene therapy, ivacaftor
- MeSH terms
- Administration, Intranasal, Animals, Cell Line, Cystic Fibrosis, Disease Models, Animal, Epithelial Cells, Female, Humans, RNA, Messenger, Transfection, Genetic Therapy, Cystic Fibrosis Transmembrane Conductance Regulator, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
